The Reproducibility and Clinical Utility of an Abbreviated Fat Tolerance Test
Study Details
Study Description
Brief Summary
This study aims to evaluate the reliability of a shortened fat tolerance test ("abbreviated fat tolerance test", or "AFTT") for measuring post-meal lipids in human blood. The reliability of the triglyceride results in this test are compared to the reliability of the glucose results from an oral glucose tolerance test (OGTT), a widely-used and clinically accepted metabolic test.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Abbreviated Fat Tolerance Test
|
Other: High-fat shake
Participant consumes a high-fat test shake. Blood is drawn before and 4 hours after this shake to measure triglycerides.
|
Active Comparator: Oral Glucose Tolerance Test
|
Other: Pure glucose solution
Participant consumes 75 grams of pure glucose. Blood is drawn before and 2 hours after this drink to measure glucose.
|
Outcome Measures
Primary Outcome Measures
- Reliability of the Change in Triglycerides after a High-Fat Meal [The two fat tolerance tests are separated by 1 week.]
Participants complete two fat tolerance tests. In each test, triglycerides are measured in blood immediately before and 4 hours after consumption of a high-fat meal. The reliability/agreement in measuring the triglyceride change between the 2 tests is being determined.
- Reliability of the Change in Glucose after Ingestion of a Glucose Solution [The two glucose tolerance tests are separated by 1 week.]
Participants complete two glucose tolerance tests. In each test, glucose is measured in blood immediately before and 2 hours after consumption of a pure glucose solution. The reliability/agreement in measuring the glucose change between the 2 tests is being determined.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Free of chronic disease
-
Normal (healthy) fasting glucose and triglycerides
Exclusion Criteria:
-
Presence of pace-maker
-
Pregnant
-
Using tobacco products
-
Using medications or dietary supplements that could modify primary outcomes
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Oklahoma State University | Stillwater | Oklahoma | United States | 74078-6104 |
Sponsors and Collaborators
- Oklahoma State University
Investigators
- Principal Investigator: Sam R Emerson, PhD, Oklahoma State University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HS1844